| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/13/2013 | CN101817792B Bistriazolone, bistriadimenol compounds with antimicrobial activity, and salts, synthesis method and uses thereof |
| 03/13/2013 | CN101805334B Lamivudin stearate and synthesis method and application |
| 03/13/2013 | CN101757328B Cold pill for treating cold and preparation method thereof |
| 03/13/2013 | CN101754763B Metal complexes incorporated within biodegradable nanoparticles and their use |
| 03/13/2013 | CN101659696B Asia I-type aftosa synthetic peptide vaccine |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101531579B Diaromatic compound with bioactivity |
| 03/13/2013 | CN101503356B Novel method for preparing high-purity chlorogenic acid |
| 03/13/2013 | CN101437824B Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 03/13/2013 | CN101309931B Vaccines comprising truncated HBC core protein plus saponin-based adjuvants |
| 03/13/2013 | CN101228169B Macrocyclic inhibitors of hepatitis c virus |
| 03/13/2013 | CN101163415B Nutritional supplement for HIV patients |
| 03/13/2013 | CN101130536B Flavanone compound and uses thereof |
| 03/12/2013 | US8394849 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 03/12/2013 | US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 03/12/2013 | US8394764 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 03/12/2013 | US8394763 Cyclic undecapeptides and derivatives as multiple sclerosis therapies |
| 03/12/2013 | US8394762 Self-decontaminating coatings containing antimicrobial peptides |
| 03/12/2013 | US8394424 Topical phytotherapeutic compound for the treatment of herpes based on Uncaria tomentosa and extraction process for obtaining a vegetal extract from Uncaria tomentosa |
| 03/12/2013 | US8394368 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 03/12/2013 | US8394361 Stable surfactant compositions for suspending components |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2571063C Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 03/12/2013 | CA2553266C Substituted quinolines and their use as mycobacterial inhibitors |
| 03/12/2013 | CA2533150C A doxycycline metal complex in a solid dosage form |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2405307C Application of substances acting as cascade inhibitors of the raf/mek/erk signaling cascade for the production of a drug against infections by dna and rna viruses |
| 03/12/2013 | CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine |
| 03/07/2013 | WO2013033518A1 Methods for treating properdin-related diseases or disorders |
| 03/07/2013 | WO2013033461A1 Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| 03/07/2013 | WO2013033363A1 Mycobacterium tuberculosis porins and toxins and related methods |
| 03/07/2013 | WO2013033092A2 Streptococcus suis pilus antigens |
| 03/07/2013 | WO2013033069A1 Human rhinovirus (hrv) antibodies |
| 03/07/2013 | WO2013033061A1 Fused bicyclic diamine derivatives as hiv attachment inhibitors |
| 03/07/2013 | WO2013033059A1 Spiro bicyclic diamine derivatives as hiv attachment inhibitors |
| 03/07/2013 | WO2013033004A2 Metalloenzyme inhibitor compounds |
| 03/07/2013 | WO2013032404A1 Human enterovirus specific antibodies and their uses in diagnostics |
| 03/07/2013 | WO2013031882A1 Vaccine preparation for cancer treatment |
| 03/07/2013 | WO2013031827A1 Rsv mucosal vaccine |
| 03/07/2013 | WO2013031694A1 Amine compound and salt thereof |
| 03/07/2013 | WO2013030778A2 Organic compositions to treat hsf1-related diseases |
| 03/07/2013 | WO2013030750A1 Antiviral compounds |
| 03/07/2013 | WO2013030735A1 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections |
| 03/07/2013 | WO2013030733A1 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
| 03/07/2013 | WO2013030604A1 Influenza virus antibody compositions |
| 03/07/2013 | WO2013030378A1 Adjuvanted formulations of staphylococcus aureus antigens |
| 03/07/2013 | WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | WO2013030208A1 Cyclosporin derivatives |
| 03/07/2013 | WO2013030058A1 Use of diclofenac |
| 03/07/2013 | WO2013029198A1 Adefovir dipivoxil solid formulation and preparation method therefor |
| 03/07/2013 | WO2013029182A1 Stable peptide-based furin inhibitors |
| 03/07/2013 | WO2012166665A3 Broad spectrum antibiotics |
| 03/07/2013 | WO2012134184A3 Novel cephalosporin derivative and medical composition containing same |
| 03/07/2013 | WO2012062873A3 Highly immunogenic hiv p24 sequences |
| 03/07/2013 | US20130060235 Pharmaceutical compositions and methods of use |
| 03/07/2013 | US20130060208 Wound care products |
| 03/07/2013 | US20130059895 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
| 03/07/2013 | US20130059890 Antiviral agents |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059882 8-Phenylisoquinolines And Pharmaceutical Composition Used In Treatment For Sepsis |
| 03/07/2013 | US20130059881 Compositions and methods for treating viral diseases |
| 03/07/2013 | US20130059880 Moxifloxacin hydrochloride compounds and intermediates and methods for making same |
| 03/07/2013 | US20130059865 Compounds having antiviral properties |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059831 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 03/07/2013 | US20130059818 Carbosilane dendrimers and the use thereof as antiviral agents |
| 03/07/2013 | US20130059812 Composition for treating chronic hepatitis b, containing clevudine and adefovir dipivoxil |
| 03/07/2013 | US20130059808 Aminoglycoside derivatives |
| 03/07/2013 | US20130059805 Composition comprising an amorphous non-crystalline glass form of azithromycin |
| 03/07/2013 | US20130059803 Boron-containing small molecules |
| 03/07/2013 | US20130059802 Boron-containing small molecules |
| 03/07/2013 | US20130059776 Antiviral Cell-Penetrating Peptides |
| 03/07/2013 | US20130059775 Nucleic Acid Complexes |
| 03/07/2013 | US20130059774 Efflux pump inhibitors |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059772 Use of Repeat Sequence Protein Polymers in Personal Care Compositions |
| 03/07/2013 | US20130059019 Methods and compositions for treating inflammation of skin |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130059004 Oral drug delivery system |
| 03/07/2013 | US20130058997 Vaccine composition containing synthetic adjuvant |
| 03/07/2013 | US20130058984 Single-walled carbon nanotube/bioactive substance complexes and methods related thereto |
| 03/07/2013 | US20130058983 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 03/07/2013 | US20130058973 Immune therapy |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058971 Innoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 03/07/2013 | US20130058969 Chloroplasts engineered to express pharmaceutical proteins |
| 03/07/2013 | US20130058968 Piscine reovirus immunogenic compositions |
| 03/07/2013 | US20130058967 Recombinant modified bacillus anthracis protective antigen for use in vaccines |
| 03/07/2013 | US20130058964 Methods for activating t cells and modulating an immune response |
| 03/07/2013 | US20130058962 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein |
| 03/07/2013 | US20130058961 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 03/07/2013 | US20130058956 Extracellular ifi16 as therapeutic agents |
| 03/07/2013 | US20130058952 Anti-hsv antibody |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058912 Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058891 Kexin-Derived Vaccines to Prevent or Treat Fungal Infections |
| 03/07/2013 | US20130058880 Film forming personal care compositions and methods |
| 03/07/2013 | US20130058871 Method and system for mapping synaptic connectivity using light microscopy |